ImageneBio, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | — | — | $82.1M |
| FY2020 | $63.5M | $168.4M | $162.5M |
| FY2021 | $40.0M | $247.9M | $232.2M |
| FY2022 | $25.3M | $172.3M | $59.9M |
| FY2023 | $22.3M | $192.1M | $119.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | — | — | $82.1M |
| FY2020 | $63.5M | $168.4M | $162.5M |
| FY2021 | $40.0M | $247.9M | $232.2M |
| FY2022 | $25.3M | $172.3M | $59.9M |
| FY2023 | $22.3M | $192.1M | $119.9M |